Technologies related to Cancer

Fluorescent Primer(s) Creation for Nucleic Acid Detection and Amplification
Ref: E-252-2013-0 | Updated: Mar 9, 2020
Photoinduced Electron Transfer Fluorescent Primer for Nucleic Acid Amplification
Ref: E-292-2013-0 | Updated: Mar 9, 2020
Potent Nucleotide Inhibitors of Ecto-5'-Nucleotidase (CD73)
Ref: E-132-2018-0 | Updated: Aug 9, 2019
A Novel Reagent for Labeling PET Tracers at Trifluoromethyl Groups
Ref: E-259-2016-0 | Updated: Jun 28, 2018
Novel Magnetic Resonance Spectroscopy (MRS) Technique to Quantify Brain Metabolites
Ref: E-206-2017-0 | Updated: May 23, 2018
MADCO-Accelerated Multidimensional Diffusion MRI
Ref: E-173-2016/0 | Updated: Dec 14, 2017
CXCR1 - Human IL-8 Receptor cDNA
Ref: B-004-1995/0 | Updated: Dec 4, 2017
Clinical Imaging with Acoustic Wave or Photoacoustic Tomosynthesis
Ref: E-114-2016/0 | Updated: Oct 10, 2017
Gene-based Diagnostic Predicts Patient Response to Cancer Immunotherapy
Ref: E-022-2017-0 | Updated: Jun 12, 2020
Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
Ref: E-120-2013-0 | Updated: Oct 2, 2017
Evans Blue Dye Derivatives for Serum Albumin Labeling
Ref: E-099-2015/0 | Updated: Aug 24, 2017
Direct Reading Detection Kits for Surface Contamination by Anti-Neoplastic (Anti-Cancer) Drugs
Ref: E-162-2013/0 | Updated: Aug 31, 2017
Multimeric Protein Toxins to Target Cells Having Multiple Identifying Characteristics
Ref: E-059-2004-0 | Updated: Jul 6, 2017
Engineered Anthrax Toxin Variants that Target Cancer
Ref: E-246-2012-0 | Updated: Jul 6, 2017
Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
Ref: E-293-1999-0 | Updated: Jul 6, 2017
Computer-Aided Diagnostic for Use in Multiparametric MRI for Prostate Cancer
Ref: E-183-2016-0 | Updated: Jun 23, 2017
Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7
Ref: E-036-2015-0 | Updated: May 17, 2017
T-cells Transduced with HLA A11 restricted CT-RCC HERV-E reactive TCR to Treat Patients with ccRCC
Ref: E-120-2016-0 | Updated: May 17, 2017
cGAP-PNA Multivalent Ligand Display at the Nanoscale
Ref: E-761-2013/0 | Updated: Apr 18, 2017
Tg(MMTV-Cre)#Mam Mouse Model for Developmental Biology, Hepatology, and Oncology Studies
Ref: E-113-2012-0 | Updated: Apr 17, 2017
Non-invasive Pan-Cancer Detection Method
Ref: E-177-2015/0 | Updated: Nov 8, 2016
Bag6 Polyclonal Antibodies That Recognize Human Bag6 Protein
Ref: E-077-2015/0 | Updated: Sep 8, 2016
Long Acting Therapeutic Conjugates with Evans Blue
Ref: E-143-2015/0 | Updated: Jun 27, 2016
Murine Cell Models for Metastatic Squamous Cell Carcinoma
Ref: E-213-2016/0 | Updated: Jun 22, 2016
Polyclonal Anti-rat Acetylserotonin Methyl Transferase (ASMT)
Ref: E-059-2016/0 | Updated: Apr 26, 2016
Metallic Nanoparticles for Photothermal Therapy
Ref: E-158-2015-0 | Updated: Jan 4, 2016
Thalidomide Analogs that Inhibit Inflammation and Angiogenesis
Ref: E-208-2015-0 | Updated: Jan 4, 2016
SIRT1 KO Human Cell Lines Generated by CRISPR/Cas9-mediated DNA Editing
Ref: E-184-2015-0 | Updated: Nov 30, 2015
A Genetic System in Yeast for Functional Identification of Human p53 Mutations
Ref: E-183-1999-0 | Updated: May 18, 2018
Genome Wide DNase I Hypersensitive Sites Detection in Formalin-Fixed Paraffin-Embedded Single Cells
Ref: E-254-2014-0 | Updated: Aug 17, 2015
Rabbit Antisera to Various Matrix, Matricellular, and Other Secreted Proteins
Ref: E-135-2008-0 | Updated: May 7, 2018
Modified AAV5 Vectors for Enhanced Transduction and Reduced Antibody Neutralization
Ref: E-097-2015-0 | Updated: May 1, 2019
A Novel Adeno-Associated Virus for Gene Therapy
Ref: E-175-2015-0 | Updated: May 1, 2019
Bispecific Chimeric Antigen Receptors to CD22 and CD19 for Treating Hematological Cancers
Ref: E-106-2015-0 | Updated: Aug 22, 2018
Boron Amino Acid Mimetics for PET Imaging of Cancer
Ref: E-135-2015/0 | Updated: Jun 29, 2015
Device for Selective Partitioning of Frozen Cellular Products
Ref: E-173-2009/0 | Updated: Jun 29, 2015
IFN Gamma for Reducing Adverse Ocular Side Effects of MEK-Inhibitor Therapy in Cancer
Ref: E-248-2012/0 | Updated: Jul 1, 2015
Novel Cancer Immunotherapy: HLA-A11 Restricted T Cell Receptor That Recognizes G12D Variant of Mutated KRAS
Ref: E-028-2015-0 | Updated: Oct 13, 2015
CXCR4 Reduction Leads to Enhancement of Engraftment of Hematopoietic Stem Cells
Ref: E-173-2014/0 | Updated: Jul 1, 2015
Highly Sensitive Tethered-Bead Immune Sandwich Assay
Ref: E-188-2014-0 | Updated: Jan 13, 2015
Ultra-sensitive Diagnostic Detects fg/mL-pg/mL Pathogen/Disease Protein by Visual Color Change
Ref: E-167-2014/0 | Updated: Sep 17, 2015
Octopod (8-Pointed Star) Iron Oxide Nanoparticles Enhance MRI T2 Contrast
Ref: E-314-2013-0 | Updated: Jun 5, 2018
T-cell Chimeric Receptors of TSLPR for Diagnosis and Immunotherapy of Cancer
Ref: E-008-2014-0 | Updated: Nov 19, 2014
A Current Amplifier for Local Coil Pre-amplification of NMR/MRI Signals
Ref: E-122-2014-0 | Updated: May 18, 2018
Chimeric Receptors Targeting CD-19
Ref: E-042-2014-0 | Updated: Oct 28, 2014
Use of Small Molecules to Treat PARP1-deficient Cancers
Ref: E-039-2014/0 | Updated: Dec 16, 2015
A Novel Demodulation System in X-ray Imaging
Ref: E-113-2013-0 | Updated: May 18, 2018
A Novel X-ray Grating to Enhance Phase Contrast Imaging
Ref: E-114-2013-0 | Updated: May 18, 2018
Novel Epstein-Barr Virus Vaccines
Ref: E-531-2013-0 | Updated: Dec 17, 2015
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Ref: E-342-2013-0 | Updated: May 14, 2018
Tumor Infiltrating Lymphocytes from Human Papillomavirus-positive Tumors for the Treatment of Cancer
Ref: E-494-2013-0 | Updated: Oct 13, 2015
Methods for the Simultaneous Detection of Multiple Analytes
Ref: E-142-2013/0 | Updated: Feb 6, 2014
Automated Microscopic Image Acquisition, Compositing and Display Software Developed for Applied Microscopy/Cytology Training and Analysis
Ref: E-228-2013/0 | Updated: Feb 6, 2014
Methods of Retaining Methylation Pattern Information in Globally Amplified DNA
Ref: E-243-2013/0 | Updated: Feb 6, 2014
Improved Personalized Cancer Immunotherapy: Rapid Selection of Tumor Reactive T Cells Based on Expression of Specific Cell Surface Markers from Peripheral Blood
Ref: E-085-2013-0 | Updated: Oct 13, 2015
Therapeutic, Bifunctional Janus Microparticles with Spatially Segregated Surface Proteins and Methods of Production
Ref: E-457-2013/1 | Updated: Jan 28, 2014
Use of Detector Response Curves to Optimize Settings for Mass Spectrometry
Ref: E-157-2013/0 | Updated: Jan 20, 2014
Chimeric Antigen Receptors to CD276 (B7-H3) for Treatment of Cancer
Ref: E-104-2013-0 | Updated: May 8, 2020
Signatures of Genetic Control in Digestive and Liver Disorders
Ref: E-349-2013-0 | Updated: Nov 17, 2015
Generation of Artificial Mutation Controls for Diagnostic Testing
Ref: E-255-2013/0 | Updated: May 24, 2016
Human Melanoma Metastasis Cell Lines Harboring Bcl-2-Like Protein 12 (BCL2L12) Mutations
Ref: E-145-2012-0 | Updated: May 8, 2018
Diagnostic Assays for the Detection of Thyroid Cancer
Ref: E-016-2013/2 | Updated: Oct 11, 2017
Pyruvate Kinase M2 Activators for the Treatment of Cancer
Ref: E-298-2011-1 | Updated: May 7, 2018
Enhanced Cancer Immunotherapy Using microRNA-155
Ref: E-272-2012-0 | Updated: Oct 12, 2015
Highly Potent and Selective Deubiquitinating Enzyme Inhibitor
Ref: E-043-2013/0 | Updated: Nov 18, 2015
mTOR Inhibition for the Prevention of Epithelial Stem Cell Loss and Mucositis
Ref: E-257-2012-0 | Updated: May 8, 2018
Human Melanoma Metastasis Cell Lines Harboring MITF Mutations
Ref: E-023-2012-0 | Updated: May 8, 2018
Human Melanoma Metastasis Cell Lines Harboring TRRAP, GRIN2A, and PLCB4 Mutations
Ref: E-024-2012-0 | Updated: May 8, 2018
Mutations in the G Protein Coupled Receptor (GPCR) Gene Family in Melanoma
Ref: E-244-2010-0 | Updated: May 8, 2018
Human Melanoma Metastasis Cell Lines Harboring GRM3 Mutations
Ref: E-029-2012-0 | Updated: May 8, 2018
The First HLA Class II Restricted T Cell Receptor that Recognizes the Cancer Testis Antigen, MAGE-A3
Ref: E-230-2012-0 | Updated: Oct 4, 2018
A Novel Immortalized Human Adrenal Cell Line with Inactive Protein Kinase A for Studies on cAMP Signaling and Endocrine Tumorigenesis
Ref: E-267-2012/0 | Updated: Nov 15, 2012
New Targeted Therapy for Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
Ref: E-060-2011/0 | Updated: Sep 10, 2012
Novel Analogues of the Asthma Drug Fenoterol as Liver and Brain Cancer Therapeutic Agents
Ref: E-139-2012/0 | Updated: Aug 1, 2012
Mouse-Derived NY-ESO-1 T Cell Receptor for Use in Immunotherapy
Ref: E-105-2012-0 | Updated: Oct 13, 2015
A3 Adenosine Receptor Agonists to Treat Chemotherapy-induced Peripheral Neuropathy
Ref: E-140-2008/1 | Updated: Jun 13, 2012
Rabbit Polyclonal Antibody to Detect a Pro-peptide Fragment of NSAID-activated Gene (NAG-1)/GDF15, a Protein Associated with Cancer
Ref: E-177-2012-0 | Updated: Apr 15, 2016
Antagonist of A3 Adenosine Receptor Fluorescent Probes for the Study of Diseases that Involve A3 Signaling
Ref: E-073-2012/0 | Updated: Feb 18, 2016
UTX LoxP Mouse Model for Oncology Research
Ref: E-118-2012/0 | Updated: Feb 23, 2016
Monoclonal Antibodies Targeting Human DNA Polymerase beta, a DNA Repair Enzyme
Ref: E-036-2008/0 | Updated: Apr 19, 2016
Stat1LoxP (Stat1 tm1Mam ) Mouse Model for Oncology and Immunology Studies
Ref: E-111-2012/0 | Updated: Mar 10, 2014
Sirt1 Knockout (Sirt1tm1.1Cxd) Mouse Model for Oncology and Metabolism Studies
Ref: E-120-2012-0 | Updated: May 14, 2018
Lenalidomide Analogs for the Treatment of Neurodegenerative Disorders and Cancer
Ref: E-045-2012/0 | Updated: Dec 14, 2017
Small-Molecule Inhibitors of Human Galactokinase for the Treatment of Galactosemia and Cancers
Ref: E-240-2011-0 | Updated: Apr 20, 2016
Model Cell Lines With and Without AKT1 Mutations Derived from Proteus Syndrome Patients
Ref: E-033-2012/0 | Updated: Oct 13, 2015
Transgenic Human Interleukin-21 Mouse Model
Ref: E-231-2010-0 | Updated: Jan 18, 2012
Enhancement of Cancer Imaging and Treatment with Somatostatin Analogs
Ref: E-252-2011/0 | Updated: Jan 17, 2012
Poly ADP-Ribose Polymerase Inhibitor/ Nitric Oxide Donor Dual Prodrugs as Anti-cancer Agents
Ref: E-220-2011-0 | Updated: Dec 19, 2013
Biomarkers for Cancer-Related Fatigue and Their Use in the Management of Such Fatigue (CRF)
Ref: E-280-2010-0 | Updated: Nov 18, 2015
Non-HLA-A2 Restricted Human T Cell Receptors to Treat Broad Cancer Population
Ref: E-266-2011-0 | Updated: Oct 12, 2015
mGluR5 Tumor Mouse Model
Ref: E-123-2010-0 | Updated: Sep 29, 2011
Platform Technology Using Ubiquitin to Improve the Delivery and Efficacy of Cytosolic Targeted Toxins
Ref: E-150-2011/0 | Updated: Sep 29, 2011
Gas Permeable Flasks to Grow Tumor Infiltrating Lymphocytes (TIL) for More Effective Anti-Cancer Immunotherapy
Ref: E-114-2011-0 | Updated: Oct 13, 2015
TRRAP and GRIN2A Mutations for the Diagnosis and Treatment of Melanoma
Ref: E-013-2011-0 | Updated: May 8, 2018
Monoclonal Antibodies for Rare Diseases
Ref: E-039-2011-0 | Updated: May 3, 2016
Mouse Model and Derived Cells That Hypersecrete Leukemia Inhibitory Factor (LIF)
Ref: E-175-2011-0 | Updated: May 3, 2016
Breakthrough Immunotherapy for Brain Cancer
Ref: E-148-2011-0 | Updated: Nov 7, 2018
NAG-1 Transgenic Mouse Model
Ref: E-093-2011-0 | Updated: Apr 17, 2013
Novel Inhibitors of Thymic Stromal Lymphopoietin (TSLP) for Cancer Therapy
Ref: E-019-2011-0 | Updated: Nov 1, 2012
Modulation of Leucine-rich Repeats and Calponin Homology Domain-containing Protein 4 (Lrch4) Activity for Therapeutic Applications
Ref: E-012-2011-0 | Updated: Apr 17, 2013


Subscribe to Technologies related to Cancer